118 related articles for article (PubMed ID: 6689276)
1. First-pass elimination of salicylamide in man following oral and rectal administration.
de Boer AG; Breimer DD; Gubbens-Stibbe JM; Bosma A
Biopharm Drug Dispos; 1983; 4(4):321-30. PubMed ID: 6689276
[TBL] [Abstract][Full Text] [Related]
2. Salicylamide pharmacokinetics in healthy males: dietary effect.
Morad AR
Biopharm Drug Dispos; 1982; 3(2):175-83. PubMed ID: 7104464
[TBL] [Abstract][Full Text] [Related]
3. Chronic quercetin feeding decreases plasma concentrations of salicylamide phase II metabolites in pigs following oral administration.
Wein S; Cermak R; Wolffram S; Langguth P
Xenobiotica; 2012 May; 42(5):477-82. PubMed ID: 22188411
[TBL] [Abstract][Full Text] [Related]
4. Rectal, oral and I.A. administration of etomidate to rats: significant avoidance of hepatic first-pass elimination following rectal administration.
de Boer AG; Breimer DD
Arch Int Pharmacodyn Ther; 1984 Aug; 270(2):180-91. PubMed ID: 6548357
[TBL] [Abstract][Full Text] [Related]
5. An assessment of mucosal damage in vivo: effect of oral pretreatment with 5-fluorouracil on the intestinal first-pass metabolism of salicylamide in rabbits.
Nakamura J; Katayama M; Nishida K; Sasaki H
Chem Pharm Bull (Tokyo); 1992 Apr; 40(4):1011-5. PubMed ID: 1525929
[TBL] [Abstract][Full Text] [Related]
6. Some quantitative evaluation of first-pass metabolism of salicylamide in rabbit and rat.
Shibasaki J; Konishi R; Koike M; Imamura A; Sueyasu M
J Pharmacobiodyn; 1981 Feb; 4(2):91-100. PubMed ID: 7277202
[TBL] [Abstract][Full Text] [Related]
7. Rectal bioavailability of lidocaine in man: partial avoidance of "first-pass" metabolism.
de Boer AG; Breimer DD; Mattie H; Pronk J; Gubbens-Stibbe JM
Clin Pharmacol Ther; 1979 Dec; 26(6):701-9. PubMed ID: 498711
[TBL] [Abstract][Full Text] [Related]
8. An assessment of indomethacin-induced mucosal damage in vivo by measuring the metabolism of salicylamide in rabbit intestine.
Nakamura J; Katayama M; Nishida K; Sasaki H
Chem Pharm Bull (Tokyo); 1992 May; 40(5):1261-5. PubMed ID: 1394644
[TBL] [Abstract][Full Text] [Related]
9. Effect of route of administration on competitive drug biotransformation interaction: salicylamide-ascorbic acid interaction in rats.
Houston JB; Levy G
J Pharmacol Exp Ther; 1976 Aug; 198(2):284-94. PubMed ID: 948026
[TBL] [Abstract][Full Text] [Related]
10. An assessment of salicylic acid-induced mucosal damage in vivo by measuring the metabolism of salicylamide in rabbit intestine.
Nakamura J; Katayama M; Nishida K; Sasaki H
Chem Pharm Bull (Tokyo); 1992 Mar; 40(3):815-8. PubMed ID: 1611698
[TBL] [Abstract][Full Text] [Related]
11. Sodium salicylamide: relative bioavailability and subjective effects.
Fleckenstein L; Mundy GR; Horovitz RA; Mazzullo JM
Clin Pharmacol Ther; 1976 Apr; 19(4):451-8. PubMed ID: 1269196
[TBL] [Abstract][Full Text] [Related]
12. Conjugation of salicylamide in the intestinal wall of dogs and rabbits.
Podder SK; Nakashima M; Nakamura T; Sasaki H; Nakamura J; Shibasaki J
J Pharmacobiodyn; 1986 Nov; 9(11):917-22. PubMed ID: 3559882
[TBL] [Abstract][Full Text] [Related]
13. Nonlinear intestinal first-pass metabolism of salicylamide in dogs after portacaval transposition.
Pond SM; Waschek JA; Mahacha V; Fielding RM; Effeney DJ; Tozer TN
J Pharmacol Exp Ther; 1988 Apr; 245(1):291-3. PubMed ID: 3361447
[TBL] [Abstract][Full Text] [Related]
14. Dose-dependent sulfoconjugation of salicylamide in dogs: effect of sulfate depletion or administration.
Waschek JA; Fielding RM; Pond SM; Rubin GM; Effeney DJ; Tozer TN
J Pharmacol Exp Ther; 1985 Aug; 234(2):431-4. PubMed ID: 4020679
[TBL] [Abstract][Full Text] [Related]
15. Salycylamide glucuronide formation in liver disease and its change by drugs.
Adachi Y; Wakisaka G; Yamamoto T
Gastroenterol Jpn; 1975; 10(2):120-31. PubMed ID: 10219
[TBL] [Abstract][Full Text] [Related]
16. Dose-dependent bioavailability and metabolism of salicylamide in dogs.
Waschek JA; Rubin GM; Tozer TN; Fielding RM; Couet WR; Effeney DJ; Pond SM
J Pharmacol Exp Ther; 1984 Jul; 230(1):89-93. PubMed ID: 6747835
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the first-pass metabolism of ethenzamide and salicylamide in rats.
Shibasaki J; Konishi R; Takemura M; Fukushima E; Nakamura J; Sasaki H
J Pharmacobiodyn; 1984 Nov; 7(11):804-10. PubMed ID: 6530645
[TBL] [Abstract][Full Text] [Related]
18. Age-related differences in salicylamide and acetaminophen conjugation in man.
Alam SN; Roberts RJ; Fischer LJ
J Pediatr; 1977 Jan; 90(1):130-5. PubMed ID: 830879
[TBL] [Abstract][Full Text] [Related]
19. On the pharmacokinetics of domperidone in animals and man. IV. The pharmacokinetics of intravenous domperidone and its bioavailability in man following intramuscular, oral and rectal administration.
Heykants J; Hendriks R; Meuldermans W; Michiels M; Scheygrond H; Reyntjens H
Eur J Drug Metab Pharmacokinet; 1981; 6(1):61-70. PubMed ID: 7250152
[TBL] [Abstract][Full Text] [Related]
20. Effect of oral pretreatment with indomethacin on the intestinal first-pass metabolism of salicylamide in rabbits.
Nakamura J; Seki N; Sasaki H; Shibasaki J
J Pharmacobiodyn; 1988 Sep; 11(9):620-4. PubMed ID: 3216283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
